CRISPR QC’s Series A Round Secures Funding from Xcellerant Ventures
San Diego-based CRISPR QC secures Series A funding from Xcellerant Ventures, driving further developments in its CRISPR Analytics Platform.
- Latest
- Trending
San Diego-based CRISPR QC secures Series A funding from Xcellerant Ventures, driving further developments in its CRISPR Analytics Platform.
OnCusp Therapeutics raises $100M in Series A funding to advance its research and development efforts in innovative therapeutics. #biotech #funding
Nasty bugs affecting popular PC games in Windows 11 previews are getting worse, causing frustration for gamers. Microsoft needs to ...
The Ethereum validator exit queue hits a record high as Celsius plans to unstake its ETH, causing a waiting time ...
Nashville-based provider Reimagine Care receives investment from Oncology Ventures to develop and expand its virtual-first cancer care offerings. #HealthcareInvestment #CancerCare ...
Dogecoin, OKB, and Everlodge are top investments for 2024 as Dogecoin surges, OKB rebounds, and Everlodge revolutionizes real estate with ...
Bitcoin's path to $250K is a mix of speculation and optimism, with Litecoin and Borroe Finance offering diverse investment opportunities ...
Apple's new Journal app offers a unique and personalized journaling experience, using data from your iPhone to generate prompts.
Borroe Finance (ROE) aims to revolutionize Web3 business funding by selling future earnings through NFTs. With AI integration for risk ...
The Samsung Odyssey Neo G8 is a top-notch 4K gaming monitor with HDR2000 and a 240Hz refresh rate, delivering lag-free ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.